Na/Ca exchange in heart failure: contractile dysfunction and arrhythmogenesis

Steven M Pogwizd1, Donald M Bers

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA. spogwidz@uic.edu

Insights

Upregulated sodium-calcium exchanger in heart failure (HF) impairs heart muscle contraction and causes dangerous arrhythmias. Therapies must balance calcium levels to manage both issues.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Congestive heart failure (HF) involves contractile dysfunction and sudden cardiac death due to ventricular arrhythmias.
  • Altered intracellular calcium handling is a key feature in HF pathogenesis.
  • The sodium-calcium exchanger (NCX) plays a critical role in regulating intracellular calcium.

Purpose of the Study:

  • To investigate the dual role of the Na/Ca exchanger in both contractile dysfunction and arrhythmogenesis in heart failure.
  • To elucidate the mechanisms by which Na/Ca exchanger activity contributes to HF.
  • To propose a new paradigm for understanding HF pathophysiology.

Main Methods:

  • The study focuses on the functional consequences of Na/Ca exchanger upregulation in HF.
  • Mechanisms investigated include sarcoplasmic reticulum (SR) calcium loading and arrhythmogenic currents.
  • Analysis of beta-adrenergic responsiveness and inward rectifier (I(K1)) currents in HF models.

Main Results:

  • Upregulation of the Na/Ca exchanger leads to sarcoplasmic reticulum unloading and contractile dysfunction.
  • The Na/Ca exchanger mediates the arrhythmogenic transient inward current (I(ti)) in HF.
  • Preserved beta-adrenergic responsiveness and decreased I(K1) currents exacerbate arrhythmogenesis in HF.

Conclusions:

  • The Na/Ca exchanger plays a dual role in heart failure, contributing to both impaired contractility and life-threatening arrhythmias.
  • Therapeutic strategies for HF must carefully manage SR calcium load to mitigate the pro-arrhythmic effects of Na/Ca exchanger activation.
  • A balanced approach is needed to address the complex roles of the Na/Ca exchanger in the failing heart.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...